Gilead SciencesvsUnitedHealth

GILD and UNH stock compared: price, dividend, valuation and results, from SEC filings.

GILD

Gilead Sciences, Inc.

$166.53

Value $207B

-1.45%
GILD's page

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

Gilead Sciences (GILD) has a market value of $207B and UnitedHealth (UNH) $300B. Over the last year, with dividends, GILD moved +34.2% and UNH +8.2%. Dividend yield: GILD 1.95%, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    GILD$207B

    UNH$300B

    UNH is 1.5 times GILD

  • Revenue, 12 months

    GILD$31.0B

    UNH$450B

    UNH is 15 times GILD

  • Net income, 12 months

    GILD-$3.9B

    UNH$15.9B

  • Operating margin

    GILD-7.6%

    UNH5.3%

    12.9 points apart

  • ROIC

    GILD-4.3%

    UNH11.3%

    15.6 points apart

  • P/E

    GILD–

    UNH18.9

  • Dividend yield

    GILD2.0%

    UNH2.7%

    0.7 points apart

  • 5-year return

    GILD+193.3%

    UNH-19.5%

    212.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

GILD+193.3%

UNH-19.5%

10020030020222023202420252026
Returns by period
PeriodGILDWith dividendsUNHWith dividends
1 year since November 18, 2025+34.2%Price +30.9%+8.2%Price +5.4%
3 years since November 17, 2023+142.6%+34.4% a yearPrice +120.7%-34.4%-13.1% a yearPrice -38.4%
5 years since November 18, 2021+193.3%+24.0% a yearPrice +145.7%-19.5%-4.2% a yearPrice -26.5%
10 years since November 21, 2016+216.4%+12.2% a yearPrice +122.1%+159.4%+10.0% a yearPrice +119.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

GILDGilead SciencesUNHUnitedHealth

Valuation

GILDUNH
Valuation
Price$166.53$330.48
Market value$207B$300B
Enterprise value (EV)$227B$346B
P/E–18.9
P/E, 5-year median18.125.0
P/B15.92.9
EV/EBIT–14.5
Free cash flow yield6.7%7.6%

Results and growth

GILDUNH
Results and growth
Revenue, 12 months$31.0B$450B
Net income, 12 months-$3.9B$15.9B
Free cash flow, 12 months$13.8B$22.8B
Earnings per share, 12 months-$3.16$17.52
Revenue growth, year on year2.4%11.8%
Revenue growth a year, past+3.6%over 5 years+11.7%over 5 years
EPS growth a year, past+132.4%over 5 years-3.8%over 5 years

Margins and returns on capital

GILDUNH
Margins and returns on capital
Gross margin79.9%88.3%
Operating margin-7.6%5.3%
Net margin-12.5%3.5%
ROIC-4.3%11.3%
ROE-20.8%15.5%

Balance sheet

GILDUNH
Balance sheet
Cash$6.4B$28.5B
Total debt$26.2B$74.3B
Net debt / EBITDA–1.6
Interest cover-2.3×6.2×

Dividends and buybacks

GILDUNH
Dividends and buybacks
Dividend yield2.0%2.7%
Dividend per share, 12 months$3.25$9.06
Dividend growth a year, past+3.0%over 5 years+12.6%over 5 years
Buyback yield0.9%1.8%
Shareholder yield2.9%4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: GILD or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Gilead Sciences or UnitedHealth?

By market value, UnitedHealth ($300B) is about 1.5 times Gilead Sciences ($207B), at today's prices.

How did GILD and UNH stock do over the last 10 years?

Since November 21, 2016, GILD's price moved +122.1% and UNH's +119.7%. With dividends: GILD +216.4% (+12.2% a year), UNH +159.4% (+10.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, GILD or UNH?

The dividend yield at today's price is 1.95% for Gilead Sciences and 2.74% for UnitedHealth. Over the last twelve months they paid $3.25 and $9.06 per share.

Which has the higher profit margins, Gilead Sciences or UnitedHealth?

Over the last twelve months, the net margin was -12.5% for Gilead Sciences and 3.5% for UnitedHealth, and the operating margin -7.6% and 5.3%. Revenue was $31.0B and $450B.

Which is the better investment, Gilead Sciences or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.